Crucial points at diagnosis: Type 2 diabetes or slow type 1 diabetes

Diabetes Care

Volumn 22, Issue SUPPL. 2, 1999, Pages

  Zimmet, Paul ^a,d   Turner, Robert ^c   McCarty, Daniel ^a   Rowley, Merrill ^b   Mackay, Ian ^b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c RADCLIFFE INFIRMARY   (United Kingdom)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; ENZYME ANTIBODY; GLUTAMATE DECARBOXYLASE; PANCREAS ISLET CELL ANTIBODY;

AGE; AUTOIMMUNITY; BODY MASS; CONFERENCE PAPER; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE COURSE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PHENOTYPE;

ADULT; AGE OF ONSET; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED;

EID: 0033011970     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (43)

1. Harris MI, Zimmet P: Classification of diabetes mellitus and other categories of glucose intolerance. In The International Textbook of Diabetes Mellitus. Keen H, DeFronzo R, Alberti KGMM, Zimmet P, Eds. London, Wiley, 1992, p. 3-18
2. Zimmet P: The challenge of diabetes. In The Medical Challenge: Complex Traits. Fisher EP, Möller G, Eds. Zurich, Piper, 1997, p. 55-110
3. Bornstein J, Lawrence RD: Plasma insulin in human diabetes mellitus. Br Med J 2:1541-1542, 1951
4. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
5. World Health Organization: Diabetes Mellitus: Second Report. Geneva, World Health Org., 1980, p. 8-12 (Tech. Rep. Ser., no. 646)
6. Zimmet P: The pathogenesis and prevention of diabetes in adults: genes, autoimmunity, and demography. Diabetes Care 18:1050-1064, 1995
7. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
8. Froguel P, Vaxillaire M, Sun F, Velho G, Zouali H, Butel MO, Lesage S, Vionnet N, Gement K, Fougerousse F, Tanizawa Y, Weissenbach-Beckman JS, Lathrop GM, Passa P, Permutt MA, Cohen D: Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 356:162-164, 1992
9. Yamageta K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pederson O, Polonsky KS, Bell GI: Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY 3). Nature 384:455-458, 1996
10. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI: Mutations in the hepatocyte factor-4α gene in maturity-onset diabetes of the young (MODY 1). Nature 384:458-460, 1996
11. Reardon W, Ross RJM, Sweeney MG, Luxon LM, Pembrey ME, Harding AE, Trembath RC: Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340:1376-1379, 1992
12. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR: Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42:358-362, 1993
13. Hagopian WA, Karlsen AE, Gottsater A, Landin-Olsson M, Grubin CE, Sundkvist G, Petersen JS, Boel E, Dyrberg T, Lernmark A: Quantitative assay using recombinant human islet glutamic acid decarboxylase (Gad65) shows that 65k autoantibody positivity at onset predicts diabetes type. J Clin Invest 91:368-374, 1993
14. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
15. Zimmet PZ, Rowley MJ, Mackay IR, Knowles W, Chen Q, Chapman L, Serjeantson S: Ethnic differences in antibodies to glutamic acid decarboxylase: concentrations in insulin-dependent diabetes mellitus in Europid and Asian subjects. J Diabetes Complications 7:1-7, 1993
16. Mølbak AG, Christau B, Marner B, Borch-Johnsen K, Nerup J: Incidence of insulin-dependent diabetes mellitus in age groups over 30 years in Denmark. Diabet Med 11:650-655, 1994
17. Scott RS, Brown LJ: Prevalence and incidence of insulin-treated diabetes mellitus in adults in Canterbury, New Zealand. Diabet Med 8:1-8, 1991
18. Lesley RDG, Pozzilli P: Type I diabetes masquerading as type II diabetes. Diabetes Care 17:1214-1219, 1994
19. Tuomilehto J, Zimmet P, Mackay IR, Koskela P, Vidgren G, Tolvalen L, Tuomilehto-Wolf E, Kohtamaki K, Stengard J, Rowley MJ: Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 343:1383-1385, 1993
20. Serjeantson SW, Court J, Mackay IR, Matheson B, Rowley MJ, Tuomi T, Wilson JD, Zimmet P: HLA-DQ genotypes are associated with autoimmunity to glutamic acid decarboxylase in insulin dependent diabetes mellitus patients. Hum Immunol 38:97-104, 1993
21. Horton VA, Stratton IM, Zimmel PZ, Mackay IR, Bottazzo GF, Shattock M, Holman RR, Turner RC: Autoantibodies in NIDDM: associations with low risk MHC class II alleles in late-onset patients (Abstract). Diabetologia 39 (Suppl. 1):A76, 1996
22. Zimmet PZ, Shaten BJ, Kuller LH, Rowley MJ, Knowles WJ, Mackay IR: Antibodies to glutamic acid decarboxylase and diabetes mellitus in the Multiple Risk Factor Intervention Trial. Am J Epidemiol 140:683-690, 1994
23. Kawasaki E, Takino H, Yano M, Uotani S, Matsumoto K, Takao Y, Yamaguchi Y, Akazawa S, Nagataki S: Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 43:80-86, 1994
24. Elbein SC, Wegner K, Miles C, Yu L, Eisenbarth G: The role of late-onset autoimmune diabetes in white familial NIDDM pedigrees. Diabetes Care 20:1248-1251, 1997
25. Castona L, Eisenbarth GS: Type I-diabetes: a chronic autoimmune disease of human, mouse and rat. Annu Rev Immunol 8:647-679,1990
26. Pittman WB, Action RT, Barger BO, Bell DS, Go RCP, Murphy CC, Roseman JM: HLA-A, -B, and -DR associations in type I diabetes mellitus with onset after age forty. Diabetes 31:122-125, 1982
27. Gleichmann H, Zarcher B, Greulich B, Gries FA, Henrichs HR, Bertrams J, Kolb H: Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults. Diabetologia 27:90-92, 1984
28. Groop LC, Bottazzo GF, Doniach D: Islet cell antibodies identify latent type 1 diabetes in patients aged 35-75 years at diagnosis. Diabetes 35:237-241, 1986
29. Groop L, Miettinen A, Groop PH, Meri S, Koskimies S, Bottazzo GF: Organ-specific auto-immunity and HLA-DR antigens as markers for B-cell destruction in patients with type 2 diabetes. Diabetes 37:99-103, 1988
30. Zimmet PZ, Tuomi T, Mackay IR, Rowley MR, Knowles W, Cohen M, Lang DA: Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299-303, 1994
31. Turner R, Stratton I, Manley S, Horton V Zimmet P, Mackay I, Bottazzo F, Shattock M, Holman RR: UKPDS2 Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 350:1288-1293, 1997
32. Whittingham S, Byron S, Tuomilehto J, Zimmet P, Myers M, Vidgren G, Rowley M, Feeney S, Koskela P, Tuomilehto-Wolf E, Mackay I: Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women. Diabet Med 14:678-685, 1997
33. King H, Senator G, Zimmet P, Harris A: The Tasmanian Insulin-Treated Diabetes Register: inception and progress in the first 12 months. Med J Aust 144:414-416, 1986
34. Riley MD, McCarty DJ, Couper DJ, Humphrey ARG, Dwyer T, Zimmet PZ: The 1984 Tasmanian Insulin Treated Diabetes Mellitus Prevalence Cohort: an 8.5 year mortality follow-up investigation. Diabetes Res Clin Pract 29:27-35, 1995
35. Humphrey ARG, McCarty DJ, Mackay IR, Rowley MJ, Dwyer T, Zimmet PZ: Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult-onset diabetes mellitus. Diabet Med 15:113-119, 1998
36. 65 produced in yeast. Clin Chem Acta 256:175-188, 1996
37. Wild T, Scherbaum WA, Gleichmann H, Landt M, Santiago J, Endl J, Landgraf R, Cavallo MG, Ganz M, Pozzilli P: Comparison of a new anti-glutamic acid decarboxylase (GAD) enzyme-linked immunosorbent assay (ELISA) with radioimmunoassay methods: a multicenter study Horm Metab Res 29:403-406, 1997
38. Skyler J, Marks J: Immune intervention in type I diabetes mellitus. Diabetes Rev 1:15-42, 1993
39. Schatz D: The Diabetes Prevention Trial-Type 1 Diabetes (DPT-1) design and implementation of the oral antigen (insulin) protocol (Abstract). Diabetes 44 (Suppl. 1):A230, 1995
40. Kuzuya T, Matsuda A: Classification of diabetes on the basis of etiologies versus degree of insulin deficiency. Diabetes Care 20:219-220, 1997
41. Banerji MA, Chaiken R, Huey H, Tuomi T, Norin AJ, Mackay IR, Rowley MJ, Zimmet PZ, Lebovitz HE: GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of HLA DR3 and DR4. Diabetes 13:741-745, 1994
42. Diabetic Control and Complications Trial Research Group: The effect of intensive treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
43. St. Paul: First Epistle to the Corinthians. Chapter 13:9,10